clinical trial · NCT00810732
Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects
Pfizer·phase2·completed·n = 27
Chronic Kidney DiseaseOpenNifedipinePlacebo
brief summary
This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.
started
May 9, 2007
primary completion
Mar 6, 2009
completion
Mar 6, 2009
last updated
Jul 6, 2023
official title
THE EFFECTS OF SITAXSENTAN ONCE DAILY DOSING ON PROTEINURIA, 24-HOUR BLOOD PRESSURE, AND ARTERIAL STIFFNESS IN SUBJECTS WITH CHRONIC KIDNEY DISEASE
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol